SPL Mapping FHIR R5 Implementation Guide
0.2.1 - Build CI United States of America flag

SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions

Example Ingredient: EnbrelPowderActiveIngredient

Page standards status: Informative

Generated Narrative: Ingredient EnbrelPowderActiveIngredient

status: Active

for: ManufacturedItemDefinition: status = active; manufacturedDoseForm = INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

role: active ingredient - basis of strength

substance

Codes

-Reference
*SubstanceDefinition: identifier = http://fdasis.nlm.nih.gov#Unique Ingredient Identifier (UNII)#OP401G7OJC

Strengths

-Presentation[x]
*25 mg (Details: UCUM codemg = 'mg')/1 mL (Details: UCUM codemL = 'mL')